•   
  •   

World COVID-19. The candidate-vaccine developed by Cuba effective at 92.28%

06:45  22 june  2021
06:45  22 june  2021 Source:   ouest-france.fr

The Doctor Who Eliminated Smallpox Says COVID-19 Is Here to Stay

  The Doctor Who Eliminated Smallpox Says COVID-19 Is Here to Stay In some pockets of the United States, if you squint hard enough, the coronavirus pandemic might feel like it’s almost over. Larry Brilliant would beg to disagree. With U.S. COVID-19 deaths soon to surpass the domestic toll from the great influenza of a century ago even as widely available vaccines have worked wonders, Brilliant, the epidemiologist who worked with the WHO to help eradicate smallpox and was the science adviser for the eerily prescient film Contagion, thinks there’s still plenty left to worry about—but also lots of good news to appreciate.

Le candidat-vaccin développé par le laboratoire cubain doit maintenant attendre le feu vert du gouvernement. © Katell Abiven / AFP The candidate-vaccine developed by the Cuban laboratory must now wait for the government's green light.

First to be done in Latin America, the Cuban vaccine candidate called Abdala would be more than 92% effective. Its approval by the government should take place in the coming days.

Candidate Vaccine Abdala Developed by Cuba against the new Coronavirus , the first created in Latin America, is 92.28% effective against the disease, announced on Monday the laboratory that put it at point.

"Abdala, CIBA Cuba Candidate, 92.28% at the end of three doses" , announced on Twitter the biocubafarma state pharmaceutical group, on which the Center of Genetic Engineering and Biotechnology depends on (Cigb).

What is the Novavax COVID-19 vaccine? Will it be available in Australia soon? And does it use mRNA?

  What is the Novavax COVID-19 vaccine? Will it be available in Australia soon? And does it use mRNA? The Novavax COVID-19 vaccine has been found to have more than 90 per cent efficacy in clinical trails, but how does it work? And does it have any side effects?The successful results from the phase 3 clinical trial of more than 30,000 volunteers in the United States and Mexico puts Novavax on track to have its two-dose vaccine approved in the US and elsewhere in the third quarter of 2021.

#abdala candidate vacunal del @cigbcuba , muestra una eficacia del 92, 28%, sucked 3 digits. #cubaescientcia pic.twitter.com/plxpythz3x - biocubafarma (@biocubafarma)

June 21, 2021

Abdala, in the final phase of clinical trials, must receive the official authorization of the Cuban authorities at the end of June or early July.

The news has been announced in person at the Cuban

President Miguel Diaz-Caneel , who then welcomed Twitter: "struck by two pandemics (Covid and the blockade), our scientists from the Institut Finlay and the Cigb have overcome all the obstacles and gave us two very effective vaccines: Soberana 2 and Abdala ».

golpeados por back pandemias (

# covid19 y #bqueeo ), nuestros científicos del finlay y cigb, Han Saltado Por Encima todos los obstáculos y our han dado back vacunas muy eftifas: # soberana02 y #abdala . pic.twitter.com/4dofjirl3o - Miguel Díaz-Canel Bermúdez (@diazanelb)

Ranked-choice voting, explained

  Ranked-choice voting, explained The hidden politics of New York City’s new system.Registered Democratic voters in New York City are getting that opportunity. Their mayoral primary on June 22 will be the city’s first to use ranked-choice voting — and that race will be the biggest spotlight yet for this system in the United States.

June 21, 2021

Saturday, the Finlay vaccination institute announced that its candidate, Soberana 2, shows an efficiency of 62% after the Injection of two of its three doses.

This is a "comforting"

result because it takes into account the variants that already circulate in the Caribbean country, had told the Vicente Local press see, director of the Institute.

This candidate must also receive the official green light shortly.

60 years of embargo

their next approval will make them the first anti-coronavirus vaccines developed and products in Latin America, even if the researchers have repeatedly denounced the difficulties encountered because of the US embargo since 1962 and reinforced under

the Trump administration.

The Cuban government aspires that in August 70% of the 11.2 million people are vaccinated, and the entire population before the end of the year.

Because of the embargo, Cuba started developing its own medicines in the 1980s. Of the thirteen vaccines of its vaccination program, eight are local production.

People are finding ways to get a COVID-19 vaccine before they're eligible. Here's where Victoria's rules stand .
Oakley Germech was frustrated AstraZeneca vaccine doses allocated for older Australians were going unused, so the 24 year old jumped the queue. Here's what you need to know about vaccine eligibility.He saw reports of a Melbourne clinic allowing any adult to receive the AstraZeneca vaccine with a signed consent form in an apparent breach of national and Victorian rules.

usr: 0
This is interesting!